{
    "clinical_study": {
        "@rank": "63887", 
        "arm_group": [
            {
                "arm_group_label": "placebo gel", 
                "arm_group_type": "Placebo Comparator", 
                "description": "scaling and root planing with placebo gel"
            }, 
            {
                "arm_group_label": "Ozonated olive oil  gel", 
                "arm_group_type": "Active Comparator", 
                "description": "scaling and root planing with Ozonated olive oil gel"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the efficacy of locally delivered ozone gel as an adjunct to conventional\n      periodontal therapy on selected clinical parameters as well as alveolar bone density (BD)\n      and superoxide dismutase (SOD) activity in patient with chronic periodontitis."
        }, 
        "brief_title": "Effect of Ozone Gel on Treatment of Chronic Periodontitis", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Periodontal Diseases", 
        "condition_browse": {
            "mesh_term": [
                "Periodontal Diseases", 
                "Periodontitis", 
                "Chronic Periodontitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study, the investigators tested the effect of  ozone gel as a local delivery system\n      in treatment of chronic periodontitis in term of probing pocket depth reduction, mean gain\n      in clinical attachment level, a more rise in BD values  as well as greater reduction in SOD\n      activity compared to scaling and root planing (SRP) alone."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. The participant's age ranged between 30 and 60 years.\n\n          2. All of the patients suffered from chronic periodontitis with attachment loss \u2265 5mm.\n\n          3. Willingness to participate and sign the informed consent.\n\n        Exclusion Criteria:\n\n          1. Any systemic disease that affect the periodontium.\n\n          2. Pregnancy, lactation, postmenopausal women\n\n          3. People who take anti-inflammatory drugs, antibiotics or vitamins within the previous\n             3 month.\n\n          4. People who use mouth washes regularly\n\n          5. Heavy smoking (> 10 cigarettes/day)\n\n          6. History of alcohol abuse.\n\n          7. Participation in other clinical trials."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02066337", 
            "org_study_id": "mn1965"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "placebo gel", 
                    "Ozonated olive oil  gel"
                ], 
                "intervention_name": "scaling and root planing", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "placebo gel", 
                "intervention_name": "placebo gel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ozonated olive oil  gel", 
                "intervention_name": "Ozonated olive oil gel", 
                "intervention_type": "Drug", 
                "other_name": "Ozonated olive oil gel = Oxactiv gel"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Superoxide Dismutase"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Ozone gel", 
            "Antioxidants", 
            "Chronic periodontitis", 
            "Superoxide dismutase"
        ], 
        "lastchanged_date": "February 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt"
                }, 
                "name": "October 6 University"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Ozone Gel on Alveolar Bone Density and Superoxide Dismutase in Chronic Periodontitis: A Randomized Controlled Clinical Study", 
        "overall_official": {
            "affiliation": "October 6 University", 
            "last_name": "Enas Elgendy, ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Superoxide dismutase activity in the gingival crevicular fluid was carried out at baseline, 1, 3 and 6 months post treatment.", 
            "measure": "Superoxide dismutase activity", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02066337"
        }, 
        "responsible_party": {
            "investigator_affiliation": "October 6 University", 
            "investigator_full_name": "Enas Elgendy", 
            "investigator_title": "Lecuture, October 6 University", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "plaque index was recorded at baseline and at 1, 3 and 6 months post treatment.", 
                "measure": "Plaque Index", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Gingival index was recorded at base line,1,3,6 months post treatment", 
                "measure": "Gingival index", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Probing pocket depth was recorded at base line, 1, 3, 6 months post treatment", 
                "measure": "Probing pocket depth", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Clinical attachment level  was recorded at baseline, 1, 3 and 6 months post treatment", 
                "measure": "Clinical attachment level", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Bone density was carried out using Digora software (Digora system, Soredex, Orion Corp., Finland) at baseline and 6 months", 
                "measure": "Bone density", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }
        ], 
        "source": "October 6 University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "October 6 University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}